JP2009541340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009541340A5 JP2009541340A5 JP2009516666A JP2009516666A JP2009541340A5 JP 2009541340 A5 JP2009541340 A5 JP 2009541340A5 JP 2009516666 A JP2009516666 A JP 2009516666A JP 2009516666 A JP2009516666 A JP 2009516666A JP 2009541340 A5 JP2009541340 A5 JP 2009541340A5
- Authority
- JP
- Japan
- Prior art keywords
- carbon atoms
- compound according
- compound
- alkyl
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 0 CC(C1*)C(C)(C)C(CO*)C1NC Chemical compound CC(C1*)C(C)(C)C(CO*)C1NC 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80528506P | 2006-06-20 | 2006-06-20 | |
| PCT/US2007/071515 WO2007149829A2 (en) | 2006-06-20 | 2007-06-19 | Therapeutic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009541340A JP2009541340A (ja) | 2009-11-26 |
| JP2009541340A5 true JP2009541340A5 (enExample) | 2010-08-05 |
Family
ID=38728727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009516666A Ceased JP2009541340A (ja) | 2006-06-20 | 2007-06-19 | 治療用化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7429669B2 (enExample) |
| EP (1) | EP2046714B1 (enExample) |
| JP (1) | JP2009541340A (enExample) |
| AU (1) | AU2007261034B2 (enExample) |
| BR (1) | BRPI0713587A2 (enExample) |
| CA (1) | CA2657967A1 (enExample) |
| WO (1) | WO2007149829A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ555945A (en) * | 2005-01-14 | 2011-01-28 | Allergan Inc | Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| US7429669B2 (en) * | 2006-06-20 | 2008-09-30 | Allergan, Inc. | Therapeutic compounds |
| JP5532302B2 (ja) * | 2006-07-10 | 2014-06-25 | アラーガン インコーポレイテッド | 治療化合物 |
| BRPI0714885B8 (pt) * | 2006-07-11 | 2021-05-25 | Allergan Inc | compostos terapêuticos e seu uso |
| AU2008207991B9 (en) * | 2007-01-22 | 2014-02-27 | Allergan, Inc. | Thiophene derivatives useful as ocular hypotensive agents |
| WO2008094958A1 (en) * | 2007-02-01 | 2008-08-07 | Allergan, Inc. | Thiophene derivatives useful as medicaments for treating ocular hypertension |
| KR20100051803A (ko) | 2007-07-03 | 2010-05-18 | 알러간, 인코포레이티드 | 안압을 감소시키기 위한 치료적인 치환된 사이클로펜탄 |
| US7662850B2 (en) * | 2007-07-13 | 2010-02-16 | Allergan, Inc. | Therapeutic substituted chlorocyclopentanols |
| US7947732B2 (en) * | 2007-07-13 | 2011-05-24 | Allergan, Inc. | Therapeutic substituted chlorocyclopentanols |
| WO2009111322A1 (en) * | 2008-03-04 | 2009-09-11 | Allergan, Inc. | Substituted cyclopentanes having prostaglandin activity |
| US8487091B2 (en) * | 2008-03-04 | 2013-07-16 | Allergan, Inc. | Substituted cyclopentanes having prostaglandin activity |
| US7964596B2 (en) * | 2008-03-07 | 2011-06-21 | Allergan, Inc. | Therapeutic compounds |
| AU2009239377B2 (en) * | 2008-04-24 | 2014-05-01 | Allergan, Inc. | Substituted arylcyclopentenes as therapeutic agents |
| ATE550328T1 (de) * | 2008-04-24 | 2012-04-15 | Allergan Inc | Thiophenderivate, die sich als den augeninnendruck senkende mittel eignen |
| US7981887B2 (en) | 2008-05-09 | 2011-07-19 | Allergan, Inc. | Therapeutic compounds |
| AU2009246573B2 (en) * | 2008-05-15 | 2014-04-24 | Allergan, Inc. | Therapeutic substituted cyclopentanes |
| AU2009251474B2 (en) * | 2008-05-15 | 2014-06-05 | Allergan, Inc. | Prostaglandin prodrugs as hypotensive agents |
| US8124648B2 (en) | 2008-05-20 | 2012-02-28 | Allergan, Inc. | Therapeutic lactams |
| DK2460801T3 (da) | 2009-07-28 | 2014-09-22 | Ono Pharmaceutical Co | Bicyklisk forbindelse samt anvendelse deraf til medicinske formål |
| WO2012102357A1 (ja) | 2011-01-27 | 2012-08-02 | 小野薬品工業株式会社 | 二環式化合物およびその医薬用途 |
| ES2581852T3 (es) | 2011-01-27 | 2016-09-07 | Ono Pharmaceutical Co., Ltd. | Compuesto bicíclico y uso del mismo para fines médicos |
| US9315486B2 (en) | 2013-10-29 | 2016-04-19 | Allergan, Inc. | Therapeutic cyclopentanols, compositions thereof, and methods for use thereof |
| JP6569661B2 (ja) * | 2014-02-27 | 2019-09-04 | 小野薬品工業株式会社 | 選択的ｅｐ２アゴニスト活性を有する化合物 |
| AU2015269064B2 (en) * | 2014-06-06 | 2020-02-13 | Allergan, Inc. | Novel EP4 agonists as therapeutic compounds |
| ES2837399T3 (es) | 2015-07-23 | 2021-06-30 | Ono Pharmaceutical Co | Derivados de ácido 2-(octahidrociclopenta(b)piran-2-il)1,3-tiazol-4-carboxílico y compuestos relacionados como agonistas de EP2 con actividad reductora de la presión intraocular |
| WO2018003945A1 (ja) | 2016-06-30 | 2018-01-04 | 小野薬品工業株式会社 | 二環式化合物の製造方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3980700A (en) | 1971-10-07 | 1976-09-14 | G. D. Searle & Co. | Prostaglandin intermediates and optically active isomers thereof |
| ZA733967B (en) * | 1972-06-15 | 1974-11-27 | Erba Carlo Spa | 9-desoxy-prosta-5,9(10),13-trienoic acid derivatives and process for their preparation |
| DE2256537A1 (de) | 1972-11-17 | 1974-10-10 | Merck Patent Gmbh | Neue sulfide |
| US4073799A (en) | 1975-02-27 | 1978-02-14 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing 3-formylcyclopentanone derivatives |
| JPS51110557A (en) | 1975-03-26 | 1976-09-30 | Sagami Chem Res | Rakutonsurufuidono seizohoho |
| US4094886A (en) | 1976-03-01 | 1978-06-13 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing allyl alcohol derivatives useful in prostaglandin synthesis |
| DE3543991A1 (de) * | 1985-12-10 | 1987-06-11 | Schering Ag | Verfahren zur herstellung von 9(beta)-chlor-prostaglandinen |
| JP2943306B2 (ja) | 1990-10-12 | 1999-08-30 | 住友化学工業株式会社 | シクロペンタンアルデヒド類およびその製造法 |
| US5688819A (en) * | 1992-09-21 | 1997-11-18 | Allergan | Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| WO1996036599A1 (en) * | 1995-05-18 | 1996-11-21 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| US6531485B2 (en) | 1997-06-23 | 2003-03-11 | Pfizer Inc. | Prostaglandin agonists |
| EP1108426A3 (en) | 1999-12-02 | 2002-10-02 | Pfizer Products Inc. | Use of prostaglandin agonists to treat erectile dysfunction or impotence |
| JP4149153B2 (ja) | 2001-09-28 | 2008-09-10 | 富士フイルム株式会社 | ポジ型レジスト組成物 |
| NZ555945A (en) | 2005-01-14 | 2011-01-28 | Allergan Inc | Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| US7323591B2 (en) * | 2006-01-10 | 2008-01-29 | Allergan, Inc. | Substituted cyclopentanes or cyclopentanones as therapeutic agents |
| US7429669B2 (en) * | 2006-06-20 | 2008-09-30 | Allergan, Inc. | Therapeutic compounds |
-
2007
- 2007-06-19 US US11/764,929 patent/US7429669B2/en active Active
- 2007-06-19 AU AU2007261034A patent/AU2007261034B2/en not_active Ceased
- 2007-06-19 BR BRPI0713587-4A patent/BRPI0713587A2/pt not_active IP Right Cessation
- 2007-06-19 CA CA002657967A patent/CA2657967A1/en not_active Abandoned
- 2007-06-19 JP JP2009516666A patent/JP2009541340A/ja not_active Ceased
- 2007-06-19 WO PCT/US2007/071515 patent/WO2007149829A2/en not_active Ceased
- 2007-06-19 EP EP07798730.3A patent/EP2046714B1/en active Active
-
2008
- 2008-08-06 US US12/187,018 patent/US8338637B2/en active Active
-
2012
- 2012-09-14 US US13/616,017 patent/US20130005767A1/en not_active Abandoned